Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Martin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nature Immunology|February 20, 2014
Self-gratification yields not-so-naive T cellsChristopher E Martin, Charles D Surh
Chemical Communications (Cambridge, England)|October 15, 2011
Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unitChristopher E Martin, Markus W Weishaupt, Peter H Seeberger
Journal of the American Chemical Society|March 26, 2013
Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteriaYou Yang, Shunsuke Oishi, Christopher E Martin, et al.
Nature Immunology|June 22, 2010
Is IL-7 from dendritic cells essential for the homeostasis of CD4+ T cells?Christopher E Martin, David M Kim, Jonathan Sprent, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 12, 2013
Homeostatic proliferation of mature T cellsChristopher E Martin, Kwesi Frimpong-Boateng, Darina S Spasova, et al.
ACS Chemical Biology|September 6, 2013
Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of LeishmaniaChakkumkal Anish, Christopher E Martin, Annette Wahlbrink, et al.
Journal of the American Chemical Society|June 26, 2013
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitopeChristopher E Martin, Felix Broecker, Matthias A Oberli, et al.
Biomacromolecules|May 29, 2015
A Self-Assembling Peptide Scaffold for the Multivalent Presentation of AntigensElsa Zacco, Chakkumkal Anish, Christopher E Martin, et al.
Chemical Communications (Cambridge, England)|July 10, 2013
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccineChristopher E Martin, Felix Broecker, Steffen Eller, et al.
Cell Chemical Biology|August 16, 2016
Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile InfectionsFelix Broecker, Christopher E Martin, Erik Wegner, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nature Immunology|February 20, 2014
Self-gratification yields not-so-naive T cellsChristopher E Martin, Charles D Surh
Chemical Communications (Cambridge, England)|October 15, 2011
Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unitChristopher E Martin, Markus W Weishaupt, Peter H Seeberger
Journal of the American Chemical Society|March 26, 2013
Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteriaYou Yang, Shunsuke Oishi, Christopher E Martin, et al.
Nature Immunology|June 22, 2010
Is IL-7 from dendritic cells essential for the homeostasis of CD4+ T cells?Christopher E Martin, David M Kim, Jonathan Sprent, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 12, 2013
Homeostatic proliferation of mature T cellsChristopher E Martin, Kwesi Frimpong-Boateng, Darina S Spasova, et al.
ACS Chemical Biology|September 6, 2013
Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of LeishmaniaChakkumkal Anish, Christopher E Martin, Annette Wahlbrink, et al.
Journal of the American Chemical Society|June 26, 2013
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitopeChristopher E Martin, Felix Broecker, Matthias A Oberli, et al.
Biomacromolecules|May 29, 2015
A Self-Assembling Peptide Scaffold for the Multivalent Presentation of AntigensElsa Zacco, Chakkumkal Anish, Christopher E Martin, et al.
Chemical Communications (Cambridge, England)|July 10, 2013
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccineChristopher E Martin, Felix Broecker, Steffen Eller, et al.
Cell Chemical Biology|August 16, 2016
Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile InfectionsFelix Broecker, Christopher E Martin, Erik Wegner, et al.
Pageof 2